Advancements in understanding positive-strand RNA viruses and their impact on health.
Official title: Positive Strand RNA Viruses: Interdisciplinary Advances in Virology, Pathogenesis, Immunology, and Technology Development
Funded at Keystone Symposia · NIH-10999347 · Data updated 2026-11-12
This study is about a conference where experts come together to share the latest ideas and discoveries about positive-strand RNA viruses, like the ones that cause COVID-19, to help improve our understanding and fight against these viruses for everyone's health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Keystone Symposia NIH-funded |
| Lab location | 1 site (Silverthorne, United States) |
| Project start | July 11, 2024 |
| Project end | June 30, 2025 |
| Funding year | 2024 |
| Award (this year) | $4,000 |
| NIH project number | 1R13AI186265-01 |
| Project ID | NIH-10999347 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals interested in the latest developments in virology and those affected by RNA virus-related diseases.
✕Less likely to help
Patients who are not affected by positive-strand RNA viruses or who do not have an interest in virology may not receive direct benefits from this research.
What this research studies
This research focuses on a conference that brings together experts to discuss the latest advancements in the study of positive-strand RNA viruses, particularly in the context of the COVID-19 pandemic. The conference will explore various aspects including virology, pathogenesis, immunology, and technology development. Attendees will share insights on virus-host interactions and the development of vaccines, aiming to foster collaboration and innovation in the field. This interdisciplinary approach seeks to enhance our understanding of these viruses and their implications for global health.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for managing and preventing diseases caused by positive-strand RNA viruses.
How similar studies have gone: Previous conferences and collaborative efforts in virology have shown success in advancing knowledge and fostering breakthroughs in vaccine development and viral research.
Where this research is happening
-
Keystone Symposia
Silverthorne, United States Active
Researchers
- Principal investigator: Sheppard, Terry L. — Keystone Symposia
- Study coordinator: Sheppard, Terry L.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.